DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Cabanillas ME, Takahashi S.
Managing the adverse events associated with lenvatinib therapy in
radioiodine-refractory differentiated thyroid cancer.
Sem Oncol 2019;
46: 57-64
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.